References
<A NAME="RG45004ST-1A">1a</A>
Yue WS.
Li JJ.
Org. Lett.
2002,
2201
<A NAME="RG45004ST-1B">1b</A>
Soldatenkov AT.
Polyanskii KB.
Soldatova SA.
Chem. Heterocycl. Compd.
2002,
38:
368
<A NAME="RG45004ST-1C">1c</A>
New JS.
Christopher WL.
Yevich JP.
Butler R.
Schlemmer RF.
Van der Maelen CP.
Cipollina JA.
J. Med. Chem.
1989,
32:
1147
<A NAME="RG45004ST-1D">1d</A>
Maffraund JP.
Eloy F.
Eur. J. Med. Chem. Chim. Ther.
1974,
483
<A NAME="RG45004ST-1E">1e</A>
Podesta M.
Aubert D.
Furand JC.
Eur. J. Med. Chem. Chim. Ther.
1974,
487
<A NAME="RG45004ST-1F">1f</A>
Makikado T. inventors; Japanese Patent 7015985.
; Chem. Abstr. 1970, 73, 77220
<A NAME="RG45004ST-1G">1g</A>
Makikado T. inventors; Japanese Patent 7033655.
; Chem. Abstr. 1971, 74, 76400
<A NAME="RG45004ST-1H">1h</A>
Simpson WRJ. inventors; Ger. Offen 2350387.
; Chem. Abstr. 1974, 81, 13555
<A NAME="RG45004ST-1I">1i</A> inventors; Centre d’Etudes de l’Industrie Pharmaceutique. Ger. Offen 2404308.
; Chem. Abstr. 1974, 81, 316131
<A NAME="RG45004ST-2A">2a</A>
Lhommet G.
Sliwa H.
Maitte P.
Bull. Soc. Chim. Fr.
1972,
1442
<A NAME="RG45004ST-2B">2b</A>
Bisagni E.
Civier A.
Marquet J.-P.
J. Heterocycl. Chem.
1975,
12:
461
<A NAME="RG45004ST-2C">2c</A>
Abramovitch RA.
Deep A.
Kishore D.
Mpango GBW.
Gazz. Chim. Ital.
1988,
118:
167
<A NAME="RG45004ST-2D">2d</A>
Hörlein G.
Kübel B.
Studeneer A.
Salbeck A.
Liebigs Ann. Chem.
1979,
371
<A NAME="RG45004ST-2E">2e</A>
Shiotani S.
Morita H.
Ishida T.
Iu Y.
J. Heterocycl. Chem.
1988,
25:
1205
<A NAME="RG45004ST-2F">2f</A>
Moron J.
Nguyen CH.
Bisagni E.
J. Chem. Soc., Perkin Trans. 1
1983,
225
<A NAME="RG45004ST-3A">3a</A>
Eloy F.
Deryckere A.
Bull. Soc. Chim. Fr.
1971,
1442
<A NAME="RG45004ST-3B">3b</A>
Eloy F.
Deryckere A.
J. Heterocycl. Chem.
1971,
8:
57
<A NAME="RG45004ST-3C">3c</A>
Bouzart JD.
Bisagni E.
Bull. Soc. Chim. Fr.
1971,
1727
<A NAME="RG45004ST-3D">3d</A>
Molina P.
Fresneda PM.
Hurtado F.
Synthesis
1987,
45
<A NAME="RG45004ST-3E">3e</A>
Krutosikova A.
Dandarova M.
Chilova J.
Vegh D.
Monatsh. Chem.
1992,
123:
807
<A NAME="RG45004ST-3F">3f</A>
Korenova A.
Krutosikova A.
Kovac J.
Celec S.
Coll. Czech. Chem. Commun.
1987,
52:
192
<A NAME="RG45004ST-3G">3g</A>
Bobosik V.
Krutosikova A.
Jordis U.
Monatsh. Chem.
1995,
126:
747
<A NAME="RG45004ST-4A">4a</A>
Khlebnikov AF.
Novikov MS.
Kostikov RR.
Russ. Chem. J.
1999,
43:
70
<A NAME="RG45004ST-4B">4b</A>
Novikov MS.
Khlebnikov AF.
Sidorina ES.
Kostikov RR.
J. Fluorine Chem.
1998,
90:
117
<A NAME="RG45004ST-4C">4c</A>
Novikov MS.
Khlebnikov AF.
Krebs A.
Kostikov RR.
Eur. J. Org. Chem.
1998,
133
<A NAME="RG45004ST-4D">4d</A>
Novikov MS.
Khlebnikov AF.
Sidorina ES.
Kostikov RR.
J. Chem. Soc., Perkin Trans. 1
2000,
231
<A NAME="RG45004ST-4E">4e</A>
Novikov MS.
Khlebnikov AF.
Besedina OV.
Kostikov RR.
Tetrahedron Lett.
2001,
42:
533
<A NAME="RG45004ST-4F">4f</A>
Voznyi IV.
Novikov MS.
Khlebnikov AF.
Kopf J.
Kostikov RR.
J. Chem. Soc., Perkin Trans. 1
2002,
1628
<A NAME="RG45004ST-4G">4g</A>
Novikov MS.
Khlebnikov AF.
Shevchenko MV.
J. Fluorine Chem.
2003,
123:
177
<A NAME="RG45004ST-4H">4h</A>
Khlebnikov AF.
Novikov M.
Amer AA.
Tetrahedron Lett.
2002,
43:
8523
<A NAME="RG45004ST-5A">5a</A>
Khlebnikov AF.
Novikov MS.
Kostikov RR.
Adv. Heterocycl. Chem.
1996,
65:
93
<A NAME="RG45004ST-5B">5b</A>
Novikov MS.
Khlebnikov AF.
Masalev AE.
Kostikov RR.
Tetrahedron Lett.
1997,
38:
4187
<A NAME="RG45004ST-5C">5c</A>
Novikov MS.
Khlebnikov AF.
Sidorina ES.
Masalev AE.
Kopf J.
Kostikov RR.
Russ. J. Org. Chem.
2002,
38:
672
<A NAME="RG45004ST-5D">5d</A>
Novikov MS.
Khlebnikov AF.
Kostikov RR.
Russ. J. Org. Chem.
2002,
38:
1647
<A NAME="RG45004ST-6A">6a</A>
McCarthy JR.
Barney CL.
O’Donnell MJ.
Huffman JC.
J. Chem. Soc., Chem. Commun.
1987,
469
<A NAME="RG45004ST-6B">6b</A>
Khlebnikov AF.
Novikov MS.
Kostikov RR.
Mendeleev Commun.
1997,
145
<A NAME="RG45004ST-7A">7a</A>
Berg-Nielson K.
Acta Chem. Scand., Ser. B
1977,
B31:
224
<A NAME="RG45004ST-7B">7b</A>
Khlebnikov AF.
Kostik EI.
Kostikov RR.
Chem. Heterocycl. Compd.
1991,
636
<A NAME="RG45004ST-7C">7c</A>
Romashin YN.
Liu MTH.
Nijjar SS.
Attanasi OA.
Chem. Commun.
2000,
1147
<A NAME="RG45004ST-7D">7d</A>
Bonneaua R.
Romashin YN.
Liu MTH.
J. Photochem. Photobiol., A
1999,
126:
31
<A NAME="RG45004ST-7E">7e</A>
Bonneau R.
Romashin YN.
Liu MTH.
MacPherson SE.
J. Chem. Soc., Chem. Commun.
1994,
509
<A NAME="RG45004ST-7F">7f</A>
Liu MTH.
Romashin YN.
Bonneau R.
Int. J. Chem. Kin.
1994,
26:
1179
<A NAME="RG45004ST-8A">8a</A>
Romashin YN.
Liu MTH.
Bonneau R.
Chem. Commun.
1999,
447
<A NAME="RG45004ST-8B">8b</A>
Romashin YN.
Liu MTH.
Ma W.
Moss RA.
Tetrahedron Lett.
1999,
40:
7163
<A NAME="RG45004ST-9A">9a</A>
Taylor EC.
Turchi IJ.
Chem. Rev.
1979,
79:
181
<A NAME="RG45004ST-9B">9b</A>
Baldwin JE.
Pudussery RG.
Qureshi AK.
Sklarz B.
J. Am. Chem. Soc.
1968,
90:
5325
<A NAME="RG45004ST-10">10</A>
Pinter A.
Nyerges M.
Viranyi A.
Töke L.
Tetrahedron Lett.
2003,
44:
2345
<A NAME="RG45004ST-11">11</A>
General Procedure for Preparation of Compounds 3 and 4.
A flask containing active lead (1.2 g, 5.8 mmol) and CH2Cl2 (7 mL) was charged with Bu4NBr (2.0 g, 6.0 mmol), imine 1a-f (2.7 mmol), and CBr2F2 (1.95 g, 9.3 mmol). The flask was tightly stopped, and the mixture was irradiated
with ultrasound at 40 °C until the lead was completely consumed. Chromatography (hexane-EtOAc,
4:1) followed by recrystallization provided compounds 4 or/and 3.
5-(4-Bromophenyl)-4,4,6,6-tetrafluoro-2-(2-fluoro-phenyl)-4,5,5a,6-tetrahydro-3a
H
-cyclo-propa[
b
]fu-ro[2,3-
c
]pyrrole (
3d): mp 135-140 °C dec. (hexane-Et2O). 1H NMR (300 MHz, CDCl3): δ = 3.88 (t, J
HF = 7.3 Hz, 1 H, 5a-H), 4.60 (dddd, J = 13.3, 6.4, 3.9, 2.6 Hz, 1 H, 3a-H), 5.93 (dd, J = 3.9, 2.6 Hz, 1 H, 3-H), 7.01-7.69 (m, 8 H, Ar-H). 13C NMR (75 MHz, CDCl3): δ = 50.5 (t, J
CF = 15.5 Hz, 1a-C), 58.4 (t, J
CF = 32.1 Hz, 3a-C), 70.0 (m, 6a-C), 98.0 (d, J
CF = 14.4 Hz, 3-C), 109.7 (ddd, J
CF = 320, 302, 9.4 Hz, 6-C), 115.3, 115.6 (d, J
CF = 21.6 Hz), 116.6 (d, J
CF = 11.6 Hz), 118.4, 123.9 (d, J
CF = 3.9 Hz), 127.3 (d, J
CF = 1.7 Hz, CAr), 128.6 (ddd, J
CF = 260, 247, 5.5 Hz, 4-C), 130.9 (d, J
CF = 8.8 Hz), 131.8, 137.7 (d, J
CF = 5.0 Hz, CAr), 152.7 (2-C), 159.9 (d, J
CF = 254 Hz, CAr-F). Anal. Calcd for C19H11BrF5NO: C, 51.38; H, 2.50; N 3.15. Found: C, 51.41; H, 2.75; N, 2.92.
6,6-Difluoro-5-phenyl-5a,6-dihydro-3a
H
-cyclo-propa[
b
]furo[2,3-
c
]pyrrol-4 (5
H
)-one (
4a): mp 87-88 °C (hexane-Et2O). IR (CHCl3): 1725 (C=O) cm-1. 1H NMR (300 MHz, CDCl3): δ = 3.96 (dd, 3
J HF = 8.2, 1.7 Hz, 1 H, 5a-H), 4.22 (dd, J = 4.5, 2.6 Hz, 1 H, 3a-H), 5.54 (dd, J = 4.5, 2.6 Hz, 1 H, 3-H), 6.62 (t, J = 2.6 Hz, 1 H, 2-H), 7.23-7.54 (m, 5 H, Ph-H). 13C NMR (75 MHz, CDCl3): δ = 49.5 (dd, J
CF = 17.7, 15.5 Hz, 5a-C), 51.6 (d, J
CF = 1.7 Hz, 3a-C), 68.2 (dd, J
CF = 19.4, 11.1 Hz, 6a-C), 100.4 (d, J
CF = 1.1 Hz, 3-C), 108.5 (dd, J
CF = 319, 301 Hz, 6-C), 120.7, 125.7, 128.8, 137.3 (CPh), 147.5 (2-C), 170.8 (dd, J
CF = 3.9, 3.2 Hz, 4-C). Anal. Calcd for C13H9F2NO2: C, 62.65; H, 3.64; N, 5.62. Found: C, 62.64; H, 3.82, N, 5.73.
<A NAME="RG45004ST-12">12</A>
General Procedure for Preparation of Compounds 8.
Compound 3 or 4 (0.52 mmol) is placed to a dry, 10 mL, one-necked round-bottomed flask and is heated
at 160 °C for 10 min. Upon cooling to r.t. a brown solid forms; recrystallization
from CH2Cl2-Et2O mixture gives furo[3,2-c]pyridine 8 as a colorless solid.
7-Fluoro-5-phenylfuro[3,2-
c
]pyridine-4 (5
H
)-one (
8a): mp 120-121 °C (CH2Cl2-Et2O). IR (CHCl3): 1630 (C=C), 1705 (C=O) cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.07 (dd, J
HH = 2.0 Hz, J
HF = 2.3 Hz, 1 H, 3-H), 7.28 (d, J
HF = 5.9 Hz, 1 H, 6-H), 7.39-7.52 (m, 5 H, Ar-H), 7.63 (d, 1 H, J
HH = 2.0 Hz, 2-H). 13C NMR (75 MHz, CDCl3): δ = 108.2 (d, J
CF = 2.2 Hz, 3-C), 117.5 (d, J
CF = 3.3 Hz, 3a-C), 119.7 (d, J
CF = 32.6 Hz, 6-C), 126.5, 128.1, 129.0 (CAr), 137.8 (d, J
CF = 239 Hz, 7-C), 140.0 (CAr), 144.6 (2-C), 148.9 (d, J
CF = 15.5 Hz, 7a-C), 156.9 (4-C). Anal. Calcd for C13H8FNO2: C, 68.12; H, 3.52; N 6.11. Found: C, 67.96; H, 3.55; N 6.08.